The impact of free licensing on innovation?

According to Gilad Sorek in an article to be published in Economics Letters Firms that make a previously patented innovation accessible to competitors increase overall likelihood of improving upon that breakthrough while also raising profits for the original innovator and market welfare [from the University of Buffalo]

Examples include Adobe putting both Postscript and PDF formats in the public domain, but one suspects few examples from the pharma domain.